The estimated Net Worth of Jack W Schuler is at least $52.4 Milion dollars as of 28 June 2024. Mr. Schuler owns over 4,737 units of Accelerate Diagnostics Inc stock worth over $32,562 and over the last 21 years he sold AXDX stock worth over $52,236,792. In addition, he makes $133,904 as Independent Director at Accelerate Diagnostics Inc.
Jack has made over 213 trades of the Accelerate Diagnostics Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he exercised 4,737 units of AXDX stock worth $7,627 on 28 June 2024.
The largest trade he's ever made was buying 8,695,652 units of Accelerate Diagnostics Inc stock on 21 November 2022 worth over $10,000,000. On average, Jack trades about 228,303 units every 15 days since 2003. As of 28 June 2024 he still owns at least 20,225 units of Accelerate Diagnostics Inc stock.
You can see the complete history of Mr. Schuler stock trades at the bottom of the page.
Jack W. Schuler serves as Independent Director of the Company. since June 26, 2012. Mr. Schuler is a founding partner of Crabtree Partners, a private equity investment firm. Mr. Schuler served as a director of Ventana Medical Systems, Inc. from 1991 and as Chairman of the Board from 1995 until Ventana’s acquisition by Roche in 2008. Mr. Schuler served as a director of Stericycle, Inc. (NASDAQ: SRCL) from March 1990 to May 2018, formerly serving as Chairman of the Board. Prior to his retirement, Mr. Schuler held various executive positions at Abbott Laboratories from December 1972 through August 1989, most recently serving as President and Chief Operating Officer. He is currently a director of Quidel Corporation (NASDAQ: QDEL). Mr. Schuler holds a B.S. in Mechanical Engineering from Tufts University and an M.B.A. from Stanford University.
As the Independent Director of Accelerate Diagnostics Inc, the total compensation of Jack Schuler at Accelerate Diagnostics Inc is $133,904. There are 8 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.
Jack Schuler is 79, he's been the Independent Director of Accelerate Diagnostics Inc since 2012. There are no older and 14 younger executives at Accelerate Diagnostics Inc.
Jack's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.
Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg oraz Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include: